InnovAge Appoints Meredith Delk as Executive Vice President and Chief Administrative Officer

Rhea-AI Summary

InnovAge (NASDAQ: INNV), a leader in providing comprehensive healthcare through the Program of All-inclusive Care for the Elderly (PACE), has appointed Meredith Delk as Executive Vice President and Chief Administrative Officer, effective September 30, 2025.

In this newly created role, Delk will oversee Pharmacy Solutions, Behavioral Health, Home Health, and Therapy service lines, while also serving as Chief External Affairs officer responsible for Government Affairs, Communications, and Marketing. Delk brings over 20 years of healthcare leadership experience, most recently leading one of the largest Medicaid PBMs in the country.

As of June 30, 2025, InnovAge serves approximately 7,740 participants across 20 centers in six states, focusing on managing care for high-cost, frail, dual-eligible seniors.

Positive

• Appointment of experienced executive with over 20 years of healthcare leadership
• New leader brings extensive experience working with 30+ states on Medicaid programs
• Strategic expansion of leadership team to drive PACE model awareness nationally

Negative

• None.

News Market Reaction

-2.83%

1 alert

-2.83% News Effect

-$20M Valuation Impact

$689M Market Cap

0.1x Rel. Volume

On the day this news was published, INNV declined 2.83%, reflecting a moderate negative market reaction. This price movement removed approximately $20M from the company's valuation, bringing the market cap to $689M at that time.

Data tracked by StockTitan Argus on the day of publication.

DENVER, Sept. 23, 2025 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (“InnovAge” or the “Company”) (Nasdaq: INNV), an industry leader in providing comprehensive healthcare programs to frail, predominantly dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE), appoints Meredith Delk as its Executive Vice President and Chief Administrative Officer, effective September 30, 2025.

Meredith Delk brings over 20 years of healthcare leadership experience to InnovAge, and until recently led one of the largest Medicaid PBMs in the country. In this newly created role at InnovAge, Delk will lead InnovAge’s Pharmacy Solutions, Behavioral Health, Home Health, and Therapy service lines as well as serve as Chief External Affairs officer overseeing Government Affairs, Communications, and Marketing.

“Meredith’s deep expertise in both pharmacy and external affairs is a strong fit for InnovAge as we continue to evolve our business to serve more seniors and drive stronger awareness of the PACE model nationally,” said Patrick Blair, CEO. “Meredith brings over two decades of healthcare experience across multiple companies in roles requiring executive operational leadership and execution particularly with government-sponsored programs. Meredith has worked with more than 30 states over the span of her career on significant policy and delivery system transformation changes across multiple Medicaid programs. Her reputation as a thoughtful leader who understands the critical work of delivering results for government partners across the country is well known and we are delighted that she is joining our team.”

Prior to working with InnovAge through her self-founded consulting firm, Delk served as Senior Vice President and General Manager leading the state government solutions division at Prime Therapeutics (previously Magellan Rx) from 2018 to 2024. Prior to that, Meredith led government affairs teams at Magellan Health, Anthem (now Elevance), and Amerigroup Corporation.

Investor Contact
Ryan Kubota
rkubota@innovage.com

Media Contact
Lara Hazenfield
InnovAge Public Relations & Content Creation Manager
lhazenfield@innovage.com

About InnovAge
InnovAge is a market leader in managing the care of high-cost, frail, and predominantly dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE). With a mission of enabling older adults to age independently in their own homes for as long as safely possible, InnovAge’s patient-centered care model is designed to improve the quality of care its participants receive while reducing over-utilization of high-cost care settings. InnovAge believes its PACE healthcare model is one in which all constituencies — participants, their families, providers and government payors — “win.” As of June 30, 2025, InnovAge served approximately 7,740 participants across 20 centers in six states. https://www.innovage.com/.

This press release was published by a CLEAR® Verified individual.

FAQ

Who is the new EVP and Chief Administrative Officer of InnovAge (NASDAQ: INNV)?

Meredith Delk has been appointed as Executive Vice President and Chief Administrative Officer of InnovAge, effective September 30, 2025.

What will be Meredith Delk's responsibilities at InnovAge?

Delk will lead Pharmacy Solutions, Behavioral Health, Home Health, and Therapy service lines, while also serving as Chief External Affairs officer overseeing Government Affairs, Communications, and Marketing.

What is Meredith Delk's previous experience before joining InnovAge?

Delk served as Senior Vice President and General Manager at Prime Therapeutics (previously Magellan Rx) from 2018 to 2024, and previously led government affairs teams at Magellan Health, Anthem (now Elevance), and Amerigroup Corporation.

How many participants does InnovAge serve as of June 2025?

InnovAge serves approximately 7,740 participants across 20 centers in six states as of June 30, 2025.

What is InnovAge's main business focus?

InnovAge is a market leader in managing care for high-cost, frail, dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE), aiming to help older adults age independently in their homes.